The largest database of trusted experimental protocols

Magnevist

Magnevist is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) procedures.
It enhances the visualization of internal body structures, allowing for more accurate diagnosis and monitoring of various medical conditions.
Magnevist works by improving the contrast between different tissues, making it easier for healthcare professionals to identify abnormalities.
When adminsitered, it temporarily alters the magnetic properties of water molecules in the body, resulting in enhanced MRI images.
Magnevist has been widely used in a variety of clinical applications, including neurological, cardiovascular, and oncological imaging.
Researchers and clinicians rely on Magnevist to optimize their MRI studies and improve patient outcomes.

Most cited protocols related to «Magnevist»

MR experiments (3 Tesla, Siemens Medical Solutions, Erlangen, Germany) were performed on a total of 39 healthy subjects (age 31±7 years, range 19–48 years, 23 males and 16 females). The protocol was approved by Institutional Review Board. Informed written consent was obtained for each participant. The body coil was used for RF transmission and a head coil was used for receiving. Foam paddings were used to stabilize the head to minimize motion. The subjects were instructed not to fall asleep during the experiments (verified after the session), as the cerebral blood flow and venous oxygenation may change during sleep. Four effective TEs were used: 0ms, 40ms, 80ms and 160ms, corresponding to 0, 4, 8 and 16 refocusing pulses in the T2-preparation (τCPMG=10ms). Other Imaging parameters: FOV=230mm, matrix=64×64, single-shot EPI, slice thickness=5mm, TR=8000ms, TE=19ms, TI=1200ms, repetition=4, thickness of labeling slab = 50 mm, gap between labeling slab and imaging slice = 25 mm, scan duration 4 minutes and 16 seconds.
In a sub-group of healthy subjects (n=6), the intra-session reproducibility was evaluated by performing five TRUST MRI scans at approximately 10 minute intervals. The same slice locations and imaging parameters were used for the five scans.
In a sub-group of healthy subjects (n=5), TR dependence of the measurement was investigated by performing TRUST MRI using TR values of 1.5 seconds to 8 seconds at 0.5 second intervals (14 different TR values). All other parameters were identical as specified above. The durations for the scans depended on TR and varied from 48 seconds to 4 minutes and 16 seconds. In one subject, the TI dependence was investigated (with fixed TR) and the TI values varied from 200ms to 2600ms (13 different TI values). All other parameters were identical as specified above.
In two healthy subjects, hypercapnia challenge (by breathing through a plastic tube with 600ml of volume, thereby increasing the dead-space (25 (link))) was induced and TRUST MRI was performed before, during, and after the challenge. End-tidal CO2 (EtCO2) was monitored throughout the experiment and was compared to MRI results.
In three healthy subjects, TRUST MRI was performed before and after 200mg caffeine tablet ingestion (26 (link)). The pre-caffeine scan was first performed. Then, while still inside the head coil, the subject was instructed to open his or her mouth for the researcher to place one tablet inside, and a small amount of water was administered via a straw to assist with swallowing. The MRI table was then repositioned to the iso-center. Twenty minutes later, the post-caffeine TRUST scan was performed. During the twenty minute waiting time, other anatomical scans (e.g. T1-weigthed anatomical imaging) were performed.
In three subjects, TRUST MRI was performed before and after the intravenous administration of Gd-DTPA contrast agent (Magnevist, Berlex Laboratories, Wayne, NY) at standard dosage (0.1 mmol/kg). The post-contrast TRUST was performed approximately 6 minutes after the injection of the contrast agent so that the agent concentration remained relatively constant for the duration of the TRUST scan.
Publication 2008
Caffeine Cell Respiration Cerebrovascular Circulation Contrast Media Ethics Committees, Research Females Gadolinium DTPA Head Healthy Volunteers Human Body Intravenous Infusion Magnevist Males MRI Scans Neoplasm Metastasis Oral Cavity Pulses Radionuclide Imaging Sleep Tablet Transmission, Communicable Disease Veins

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Allergic Reaction Diastole ECHO protocol Electrocardiography Eligibility Determination Epistropheus Fibrosis Inversion, Chromosome Magnevist Myocardium Pentetic Acid Pharmaceutical Preparations Physical Examination Precipitating Factors Pulse Rate Torso
DCE liver MRI was performed in six healthy volunteers (age 34.5±5.2 years) and seven patients (age 51±8.4 years) in axial orientation during free breathing using whole-body 3-T or 1.5-T scanners (MAGNETOM Verio / Avanto, Siemens AG, Erlangen, Germany) with a combination of body-matrix and spine coil elements with 12 channels in total. Data acquisition was initiated simultaneously with intravenous injection of 10 ml of gadopentate dimeglumine (Gd-DTPA) (Magnevist, Bayer Healthcare, Leverkusen) followed by a 20-ml saline flush, both injected at a rate of 2 ml/second. A radial stack-of-stars 3D Fast Low Angle SHot (FLASH) pulse sequence with golden-angle ordering was employed for the data acquisitions. Two-fold readout oversampling was applied to avoid spurious aliasing along the spokes. All partitions corresponding to one radial angle were acquired sequentially before moving to the next angle. The ordering scheme along kz was switched between linear (from kz=-kzmax/2 to kz=+kzmax/2) and centric out (starting at kz=0) depending on the number of slices, as done in most of the modern 3D gradient echo (GRE) sequences. Frequency-selective fat suppression was used and 60 initial calibration lines were acquired to correct system-dependent gradient-delay errors as described in (38 ). Relevant imaging parameters are listed in Table 1.
Publication 2013
ECHO protocol Flushing Gadolinium DTPA Healthy Volunteers Human Body Liver Magnevist Patients Saline Solution Stars, Celestial Vertebral Column

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
Adult Animals Brain Callithrix Callitrichinae Contrast Media Diffusion Diffusion Magnetic Resonance Imaging ECHO protocol Epistropheus Females Formalin Gadopentetate Dimeglumine Magnevist Males Neurites Vibration

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Brain ECHO protocol Gadolinium Gadopentetate Dimeglumine Homo sapiens Human Body Hypersensitivity Inversion, Chromosome Magnevist Microtubule-Associated Proteins MRI Scans Patients Pulse Rate Reading Frames SHIMS Transmission, Communicable Disease Veins

Most recents protocols related to «Magnevist»

The examination was performed using a 3.0 T magnetic resonance scanner (Skyra; Siemens AG, Erlangen, Germany), which used a dedicated 16-channel phased-array coil. Patients underwent breathing training prior to examination to reduce respiratory motion artifacts. The following acquisition parameters were applied: coronal T2WI half-Fourier acquisition single-shot turbo spin echo (HASTE): rotation time (TR), 1,400 ms; echo time (TE), 87 ms; field of view (FOV), 400 mm × 400 mm; FOV, 1.3×1.3; slice thickness, 5 mm; slices, 24. Axial T2WI BLADE [which is also named periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER)]: TR, 3,000 ms; TE, 87 ms; FOV, 400 mm × 400 mm; FOV, 1.3×1.3; slice thickness, 5 mm; slices, 24. Axial T1WI three-dimensional volumetric interpolated breath-hold examination (VIBE-3D): TR, 4.11 ms; TE, 1.22 ms; FOV, 420 mm × 420 mm; FOV, 1.3×1.3; slice thickness, 3.5 mm. diffusion-weighted imaging (DWI): b value, 50,800 s/mm2; TR, 5,600 ms; TE, 72 ms; FOV, 400 mm × 400 mm; FOV, 1.6×1.6; slice thickness, 5 mm; and slices, 24. A dose of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) [Magnevist; 0.1 mmol/kg (0.2 mL/kg)] was injected as a quick bolus into the cubital vein at a rate of 3.0 mL/s by using a double-barrel high-pressure syringe. Allergy testing was performed before contrast injection to ensure patient safety. Radiomic features were extracted from chest axial T2WI.
The CT images were scanned using Toshiba (Tokyo, Japan), Philips (Amsterdam, Netherlands), and Siemens CT scanners. The default values of the scanners included tube voltage 120 kV and tube current 110–240 mA. After the real-time dynamic dose mapper was turned on, the relevant parameters included: collimation, 192 mm × 0.6 mm; TR, 0.25 s; pitch, 0.9; and slice thickness, 5 mm. The patient was asked to take a supine position, with both upper limbs naturally raised. The head was advanced first, and routine chest scan was performed at the end of the deep inspiration. The scan ranged from the thoracic inlet to the level 5 cm below the costophrenic angle. All CT images were reviewed with the lung window [window width, 1,500 Hounsfield units (HU); window level, −500 HU] and the mediastinal window (window width, 400 HU; window level, 45 HU), with the reconstructed slice thickness being 1 mm.
Publication 2023
Allergic Reaction CAT SCANNERS X RAY Chest Diffusion ECHO protocol Forearm Gadolinium DTPA Head Inhalation Lung Magnevist Mediastinum Nuclear Magnetic Resonance Patients Patient Safety Pressure Radionuclide Imaging Reconstructive Surgical Procedures Respiratory Rate Syringes Upper Extremity Veins
The SD rats fasted for 12 h, drank water, and were in the prone position. Spontaneous breathing was maintained under sevoflurane inhalation anesthesia, with sevoflurane 2 l/min + oxygen 2 l/min inhalations. The body temperature was kept at 36.5–37.5 °C during imaging. All imaging protocols were performed on a 3.0 T MRI instrument (750Discover, General Electric Company, GE) and the animal special coil (eight-channel rat coil for GE). After scanning the basic value of the rat spinal cord, 25 μl 7.5% Magnevist (Gd-DTPA, Gadolinium-diethylenetriamine Penta-acetic acid, 469. 01 mg/ml, MW 938 Da, Bayer, Leverkusen, Germany) was slowly injected into the subarachnoid space of rats at L4–5 spaces in 5 min. After the injection, the puncture needle stayed in position for 3 min. Then, the scan was performed immediately. Scanning was performed before intrathecal injection of Gd-DTPA and 15, 30, 60, 90, 120, 150, 180, and 300 min after Gd-DTPA injection. During the absence of a scan, the rats were allowed to wake up, drank water freely, and were kept warm. The signal value was measured by the RadiAnt DICOM software (64bit, Version 2021.1, Medixant, Poznan, Poland). The spinal clearance rate equals the spinal cord signal difference (peak value minus 6th-hour signal intensity) divided by time.
Publication 2023
Acetic Acid Anesthesia, Inhalation Animals Body Temperature diethylenetriamine Electricity Gadolinium Gadolinium DTPA Inhalation Intrathecal Injection Magnevist Metabolic Clearance Rate Needles Oxygen Punctures Radionuclide Imaging Rattus Sevoflurane Spinal Cord Subarachnoid Space Tetranitrate, Pentaerythritol
Using late gadolinium enhancement after 15 minutes of contrast administration (0.15 mmol of intravenous gadopentetate dimeglumine [Magnevist; Bayer Healthcare Pharmaceuticals, Montville, NJ]), a myocardial scar was defined through a focal enhancement in 2 adjacent short‐axis slices or 1 short‐axis and a long‐axis image at the exact location.25 Manually, using the QMass research software (version 7.2; Medis, Leiden, the Netherlands), myocardial scars were quantified as a percentage of left ventricular mass. Typical scars were considered ischemic in nature if they involved the subendocardium in coronary artery distribution. In contrast, if they involved the subepicardium or midwall, they would be atypical or nonischemic. Using the full width at half‐maximum criterion, the area of the myocardial scar was manually defined as the area with increased signal intensity.26, 27 Our cohort had a total of 111 (9%) myocardial scars. Studies that evaluated myocardial scar in the MESA have been previously published.25, 26, 28
Publication 2023
Artery, Coronary Cicatrix Epistropheus Gadolinium Gadopentetate Dimeglumine Left Ventricles Magnevist Myocardium Pharmaceutical Preparations
MRIs were acquired using 1.5T (GE Signa Scanner, General Electric Medical Systems) or 3T (Philips Achieva, Philips Healthcare; Siemens Skyra, Siemens AG) scanners. Parameters for FLAIR acquisition were: repetition time (TR), 9000 ms; echo time (TE), 120–145 ms; 3.5 mm slice thickness (40 slices). Dynamic susceptibility contrast PWI parameters were: TR, 1–1.5 s; TE, 25–45 ms; 7 mm slice thickness (20 slices with a full brain coverage); 40–80 dynamics. For PWI, participants received 0.1 mmol/kg of gadolinium–diethylenetriamine penta-acetic acid (Magnevist, Bayer Schering Pharma) or gadobenic acid MultiHance (Bracco Diagnostics) contrast at 5 mL/s flow rate.
Full text: Click here
Publication 2023
Acetic Acid Brain Diagnosis diethylenetriamine ECHO protocol Electricity gadobenic acid Gadolinium Magnetic Resonance Imaging Magnevist MultiHance Susceptibility, Disease Tetranitrate, Pentaerythritol
Two separate scanners (GE, Signa HDxt 1.5 T, and Siemens, MAGNETOM Skyra 3.0 T) were used for the MRI exams. Prior to the examination, the patient had to fast for at least 4 h and fill their bladder with moderate amounts of water. The 1.5 T scanning parameters were as follows: T2FSE:TR/TE 6680 ms/130 ms; slice thickness, 4 mm; gap, 1 mm; field of view, 35–40 cm; DWI (TR/TE, 7000 ms/77.5 ms), b value, 1000 s/mm2; and contrast-enhanced T1WI (LAVA, T1CE):TR/TE, 4.2 ms/2.1 ms) gadopentetate dimeglumine (Magnevist, Bayer Schering) was injected at a rate of 2.0 mL/s for the contrast-enhanced pictures. The 3.0 T scanning parameters were as follows: T2FSE:TR/TE 3000 ms/87 ms; slice thickness, 5 mm; field of view, 35 cm; DWI (TR/TE, 5700 ms/92 ms), b value, 800 s/mm2; and contrast-enhanced T1WI (VIBE, T1CE):TR/TE 3.5 ms/1.4 ms; slice thickness, 2 mm; gadopentetate dimeglumine (Magnevist, Bayer Schering) was injected at a rate of 2.0 mL/s and then repeated at 25–30, 60–90, and 180 s into the examination.
Full text: Click here
Publication 2023
Gadopentetate Dimeglumine Magnevist Patients Tandem Mass Spectrometry Urinary Bladder

Top products related to «Magnevist»

Sourced in Germany, United States, Japan, China, United Kingdom, Jersey, Canada, Ireland
Magnevist is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) procedures. It is designed to enhance the visualization of internal body structures and improve the diagnostic capabilities of MRI scans.
Sourced in Germany, United States, Japan, Canada, Switzerland, United Kingdom, France, Spain
Gadovist is a contrast agent used in magnetic resonance imaging (MRI) procedures. It contains the active ingredient gadobutrol, which enhances the visibility of certain structures within the body during the MRI scan.
Sourced in Germany, United States, Japan, United Kingdom
The Magnetom Verio is a magnetic resonance imaging (MRI) system produced by Siemens. It is designed to acquire high-quality images of the human body. The core function of the Magnetom Verio is to generate a strong magnetic field and radio waves, which interact with the hydrogen protons in the body to produce detailed images of internal structures and organs.
Sourced in Germany, United States, France
The Magnetom Avanto is a magnetic resonance imaging (MRI) system developed by Siemens. It is designed to provide high-quality imaging for a variety of clinical applications. The Magnetom Avanto utilizes a strong magnetic field and radio waves to generate detailed images of the body's internal structures.
Sourced in France, Germany, United States, United Kingdom, Italy
Dotarem is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) procedures. It is designed to enhance the visualization of internal body structures during MRI scans.
Sourced in Italy, Germany, United States, China
MultiHance is a contrast agent used in magnetic resonance imaging (MRI) procedures. It is a paramagnetic agent that enhances the visualization of internal body structures during the MRI scan. The core function of MultiHance is to improve the contrast between different tissues, allowing for better detection and evaluation of potential abnormalities.
Sourced in Netherlands, Germany, United States, United Kingdom, Japan
The Philips Achieva is a versatile laboratory equipment designed for a range of analytical and research applications. It offers advanced capabilities for tasks such as sample preparation, separation, and detection. The Achieva is engineered to provide reliable and consistent performance, making it a valuable tool for various scientific disciplines.
Sourced in Netherlands, Germany, United States, Switzerland, Japan
The Philips Ingenia is a magnetic resonance imaging (MRI) system designed for diagnostic imaging. It provides high-quality images of the body's internal structures to aid in the detection and diagnosis of various medical conditions.
Sourced in United States, United Kingdom, Germany, Japan, France
The Signa HDxt is a magnetic resonance imaging (MRI) system developed by GE Healthcare. It is designed to provide high-quality, high-resolution medical images for diagnostic purposes. The core function of the Signa HDxt is to generate detailed images of the body's internal structures using strong magnetic fields and radio waves.
Sourced in Germany, United States, United Kingdom, China
The Tim Trio is a versatile laboratory equipment that serves as a temperature-controlled magnetic stirrer. It features three independent stirring positions, allowing simultaneous operation of multiple samples. The device maintains a consistent temperature range to ensure accurate and reliable results during experimental procedures.

More about "Magnevist"

Magnevist is a gadolinium-based contrast agent (GBCA) commonly used in magnetic resonance imaging (MRI) procedures.
It is designed to enhance the visualization of internal body structures, allowing healthcare professionals to more accurately diagnose and monitor various medical conditions.
Magnevist works by temporarily altering the magnetic properties of water molecules in the body, resulting in improved contrast between different tissues and making it easier to identify abnormalities.
Magnevist has been widely utilized in a variety of clinical applications, including neurological, cardiovascular, and oncological imaging.
Researchers and clinicians rely on Magnevist to optimize their MRI studies and improve patient outcomes.
Synonyms for Magnevist include Gadovist, Dotarem, and MultiHance, all of which are GBCAs used in MRI procedures.
Related terms and abbreviations include MRI (magnetic resonance imaging), GBCA (gadolinium-based contrast agent), and MRA (magnetic resonance angiography).
Key subtopics associated with Magnevist include contrast enhancement, tissue visualization, diagnostic accuracy, clinical applications, and research optimization.
Other MRI-related technologies mentioned in the metadescription include Magnetom Verio, Magnetom Avanto, Achieva, Ingenia, and Signa HDxt, all of which are MRI scanners manufactured by leading healthcare technology companies.
The Tim Trio is a specific MRI system that may be used in conjunction with Magnevist for enhanced imaging capabilities.
Typo: Optmize your Magnevist studies with PubCompare.ai's cutting-edge technology.